5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
Global Pharmaceutical Logistics Market is segmented by mode of transport (Air, Trucking, Ocean), By type of operation (Cold Chain, Non Cold Chain), by Geography(North America, Europe, APAC, Latin America, Rest of the World), by Drug Supply stage (Outcourced, In-House) - Growth, Trends, and Forecast (2019-2024)
Fastest Growing Market:
The Global Pharmaceutical Logistics Market is expected to grow at a Cagr of 4.1% in the forecast period of 2019-2024. The market growth is attributed to the increasing demand for the household healthcare products and raising importance of fast track assistance. Additionally, there is a growing need for maintaining the cold chain integrity for pharmaceutical products and decreasing the distribution cost by creating a single source distribution channel is further boosting the demand of pharmaceutical logistics. Research suggests that logistics costs comprises of about 45-55% of the costs in the Indian Pharmaceutical supply chain from factory to shelf. Logistics has long been considered as a basic supporting function within the life sciences sector.
The importance of logistics is growing for a number of reasons as listed below:
(1) The rising relevance of the emerging markets and globalization of supply chains
(2) Increased regulatory efforts specifically around the temperature management
(3) A changing product portfolio that, on the one hand, allows new direct-to-market approaches notably for specialties and, on the other hand, necessitates differentiated ‘value-focused’ approaches for value products and generics, where the cost of logistics drives a larger share of total cost.
Other key factors that are driving the logistics market in the life sciences industry are:
Expansion of many pharmaceutical and medical device manufacturers to tier 2 and tier 3 cities and also to certain rural areas in emerging countries.
A complete background analysis of the Global Pharmaceutical Logistics Market, which includes an assessment of the economy and contribution of sectors in the economy, market overview, market size estimation for key segments, and emerging trends in the market segments, market dynamics is covered in the report.
|By Mode of Transport|
|By type of operation|
|Rest of the World|
|By Drug Supply stage|
Report scope can be customized per your requirements. Click here.
Non cold chain products exhibit higher sales over cold chain products in general all over the world. The non-cold chain spending is expected to grow at a cagr of ~2% from 2016 to 2022. A nominal increase in the cold-chain products is also expected due to the ongoing transition to bio-based products, rigorous preconditions of life science shipments coupled with the growing globalization of the pharmaceutical trade.
Cold-chain products require colder temperatures throughout the storage, handling, and transportation processes to maintain product integrity. Biopharma products are manufactured or extracted from various biological sources such as vaccines, blood and its components, as well as gene therapies.
To understand key trends, Download Sample Report
During the period of 2000-2016, the global pharmaceutical air trade has more than doubled. The demand for pharmaceutical logistics is growing in U.S. on account of the increasing sales of generic drugs, as well as reforms in the healthcare sector favoring generics. The market in the North America region is significantly fragmented owing to the presence of a large number of regional and international companies.
To understand geography trends, Download Sample Report.
The market is highly competitive with many companies striving to offer cloud-based supply chain solutions and a secured supply chain functions. These kind of technological implementation help manufacturers in verifying the authenticity of the drugs, thus avoiding the production of counterfeit drugs and medical devices. Numerous companies are entering into merger and acquisition to expand their geographical presence and their proprietary knowledge. They are also focusing on reducing the overall packaging costs of their products. In addition, economic reforms have led to the growth of the global market.
1.1 Scope of the Study
1.2 Key Deliverables of the Study
1.3 Study Assumptions
2. RESEARCH METHODOLOGY
2.1 Analysis Methodology
2.2 Research Phases
3. EXECUTIVE SUMMARY
4. GOVERNMENT REGULATIONS AND INITIATIVES
5. MARKET DYNAMICS
5.1 Current Market Scenario
5.2 Market Dynamics
5.3 Industry Attractiveness - Porter's Five Forces Analysis
5.4 Value Chain/ Supply Chain Analysis
6. MARKET SEGMENTATION
6.1 By Mode of Transport
6.2 By type of operation
6.2.1 Cold chain
6.2.2 Non cold chain
6.3.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
6.3.3 Asia Pacific
220.127.116.11 South Korea
6.3.4 Latin America
6.3.5 Rest of the World
6.4 By Drug Supply stage
7. COMPETITIVE LANDSCAPE
7.1 Overview (Market Concentration and Major Players)
7.2 Company Profiles
7.2.1 Deutsche Post DHL
7.2.2 Kuehne + Nagel
7.2.3 UPS (Marken)
7.2.4 DB Group
7.2.6 Nippon Express
7.2.7 World Courier
7.2.8 SF Express
7.2.13 Kerry Logistics
7.2.14 CH Robinson
7.2.15 Air Canada Cargo
7.2.16 Americold Logistics
7.2.17 Lineage Logistics
7.2.18 United States Cold Storage
7.2.19 AGRO Merchants Group, LLC
7.2.20 Nichirei Logistics Group, Inc.
7.2.22 NewCold Advanced Cold Logistics
7.2.23 VersaCold Logistics Services
7.2.24 Cloverleaf Cold Storage Co.
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
10. DISCLAIMER AND ABOUT US
* List Not Exhaustive